Human actinomycetoma caused by Actinomadura mexicana in Sudan: the first report.


Journal

Transactions of the Royal Society of Tropical Medicine and Hygiene
ISSN: 1878-3503
Titre abrégé: Trans R Soc Trop Med Hyg
Pays: England
ID NLM: 7506129

Informations de publication

Date de publication:
14 04 2021
Historique:
received: 18 09 2020
revised: 09 10 2020
accepted: 08 11 2020
pubmed: 1 1 2021
medline: 25 6 2021
entrez: 31 12 2020
Statut: ppublish

Résumé

Mycetoma is a localized, chronic, granulomatous disease that can be caused by fungi (eumycetoma) or bacteria (actinomycetoma). Of the 70 different causative agents implicated in mycetoma worldwide, Actinomadura madurae is the only one that causes multiple cases on all continents. Recently, new Actinomadura species were described as causative agents of human mycetoma. One of these new causative agents was Actinomadura mexicana, which was identified in Latin America. Here we demonstrate that this causative agent is not confined to Latin America and that it is also a causative agent of actinomycetoma in Sudan. The disease was managed by antibiotic treatment alone and resulted in complete cure after 6 months of treatment, which is quick when compared with actinomycetoma cases caused by other Actinomadura species.

Identifiants

pubmed: 33382899
pii: 6056655
doi: 10.1093/trstmh/traa145
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

406-410

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.

Auteurs

Emmanuel Edwar Siddig (EE)

Mycetoma Research Centre, University of Khartoum, P.O. Box 102, Khartoum, Sudan.
Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands.

Bertrand Nyuykonge (B)

Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands.

Mohammed Tayfour Ahmed (MT)

Mycetoma Research Centre, University of Khartoum, P.O. Box 102, Khartoum, Sudan.

Rowa Hassan (R)

Mycetoma Research Centre, University of Khartoum, P.O. Box 102, Khartoum, Sudan.
Brighton and Sussex Centre for Global Health Research, Brighton and Sussex Medical School, Brighton, UK.

Eiman Siddig Ahmed Saad (ESA)

Mycetoma Research Centre, University of Khartoum, P.O. Box 102, Khartoum, Sudan.

Najwa Adam Mhmoud (NA)

Mycetoma Research Centre, University of Khartoum, P.O. Box 102, Khartoum, Sudan.

Sahar Mubarak Bakhiet (SM)

Mycetoma Research Centre, University of Khartoum, P.O. Box 102, Khartoum, Sudan.
Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.

Wendy W J van de Sande (WWJ)

Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands.

Ahmed Hassan Fahal (AH)

Mycetoma Research Centre, University of Khartoum, P.O. Box 102, Khartoum, Sudan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH